Björn Redfors Group
Short description
Björn Redfors is associate professor at Sahlgrenska academy, University of Gothenburg and consultant cardiologist at Sahlgrenska university hospital.
About Redfors Lab
The Redfors lab is a translational team consisting of two integrated units: the clinical unit and the pre-clinical unit. Most group members contribute to both units. The clinical unit is located at the Department of Cardiology and focuses on prospective studies of patients with ST-elevation myocardial infarction (STEMI) who are treated with primary percutaneous coronary intervention. The cardiology clinic at Sahlgrenska University Hospital is the largest percutaneous coronary intervention center in Sweden. Approximately 20% of all patients with STEMI in Sweden are treated at Sahlgrenska, making the cardiology clinic at Sahlgrenska well suited for this type of research. The clinical unit of the Research lab is closely integrated with the Cardiology department’s research infrastructure, which includes facilities for invasive and non-invasive evaluation of cardiovascular function. Dr Redfors and several other group members are practicing cardiologists.
The preclinical unit is located at the Wallenberg laboratory and at the facilities for Experimental Biomedicine (EBM). The preclinical work focuses on animal models of myocardial ischemia-reperfusion injury, which is an experimental model for STEMI, as well as ex-vivo models of myocardial ischemia. The infrastructure of WCMTM, Wallenberglaboratory and the core facilities at Sahlgrenska Academy provide access to state-of-the-art experimental techniques as well as broad collaborative networks within molecular biology.
The clinical and preclinical units are intimately linked, with most team members conducting work within both units. Within the overarching aim of the research group, the research is dynamic and new hypotheses are developed and fine-tuned based on the interpretations of findings made in the clinical and preclinical setting. Observations made in the clinical context are subsequently examined in greater detail in the more controlled preclinical setting.
Dr. Redfors is a consultant cardiologist at the Department of Cardiology at Sahlgrenska University Hospital and Associate Professor of Cardiology at the University of Gothenburg. He is also Assistant Professor of Medicine at Columbia University, New York. He is the recipient of several prestigious research grants and has authored over 150 original peer-reviewed manuscripts. Dr Redfors has an extensive international collaborative network within interventional cardiology.
Contact Information
Visiting address
Blå stråket 5 b wallenberglab/su
41345 Göteborg
Postal address
SU Sahlgrenska
41345 Göteborg
Group members
Shafaat Hussain Turi, PhD
Postdoc
Dr Shafaat Hussain Turi is a Postdoctoral Research Fellow in Experimental Cardiology at the Department of Molecular and Clinical Medicine University of Gothenburg, Sweden, under the mentorship of Dr Björn Redfors. He earned his MS in Molecular Life Sciences (mentor, Dr Cesare Patrone) from Stockholm University & Karolinska Institutet, where his research focused on diabetes, stroke, and neurodegeneration. In 2019, Dr Turi received a PhD in Medicine (mentors, Dr Francesco Cosentino and Dr John Pernow) from Karolinska Institutet. Then, he worked as a Lab Manager at Biopromic AB and an Affiliated Researcher at Cardiology Unit, Karolinska Institutet. His research aims to unveil novel molecular and cellular mechanisms underlying vascular and cardiac dysfunction in cardiovascular diseases that can be turned into diagnostic and therapeutic strategies. He enjoys working with his team members in the lab with different backgrounds. In his spare time, he enjoys traveling, mentoring, and individual sports.
Aaron Shekka Espinosa, MD
PhD student
Aaron Shekka Espinosa is a PhD-student in Björn Redfors group at the Department of Molecular and Clinical Medicine at the University of Gothenburg. Aaron completed a BS in biomedical sciences from Karolinska Institute in 2014 and received his medical degree in 2020 from the University of Gothenburg. Aaron is a team player and enjoys working and collaborating in the lab with people from different backgrounds. In his spare time, he enjoys traveling, teaching, playing video games, and working out.
Yalda Kakaei
PhD student
Yalda Kakaei is a PhD-student in Björn Redfors group at the Department of Molecular and Clinical Medicine at the University of Gothenburg. She received her MS degree in Molecular Biotechnology from Skövde University & Sahlgrenska cancer center, where she studied the relationship between cisplatin and redox signaling pathways with Dr. Naredi. Besides her research passion, she enjoys playing chess, solving puzzle games, watching movies, and traveling in her spare time.
Ahmed Elmahdy, MD
PhD student
Ahmed Elmahdy a PhD student in Björn Redfors Group at the Department of Medicine & Department of Molecular and Clinical Medicine at the University of Gothenburg, Sweden. I obtained my medical degree from Mansoura Faculty of Medicine, Egypt in 2019. In September 2019, he was awarded the Swiss Government Excellence Scholarship to conduct a one-year research fellowship under the supervision of Dr Annalisa Berzigotti at Inselspital, Bern. On the free time, I like cinema, football, and spends time with family and friends.
Mana Kalani
PhD student
Mana Kalani studied Master of science in Molecular Biology at University of Gothenburg in 2012. She worked for several years as research assistant, biologist and consultant in research projects, both in the private and public sector. Mana has experience with several different laboratory techniques and methods, and has worked with several different model organisms. Mana considers research to be a special lifestyle which requires a lot of passion and enthusiasm!
Angela Poller
PhD student
Angela Poller is a biomedical analyst at Clinical Physiology at the Sahlgrenska University Hospital and has been doing echocardiography since 2011. She is also a PhD-student in Björn Redfors group at the department of Molecular and Clinical Medicine at the University of Gothenburg. She joined the group in 2020. She is involved in all the clinical studies. She is responsible of the imaging modalities with special interests in echocardiography and MRI. In her spare time, she loves spending time with her family and friends and to work out, mainly cardio training. She spends a lot of time in the swimming arena since both of her children are competitive swimmers.
Sandeep Jha, MD
PhD student
Sandeep Jha is a consultant in internal medicine and cardiology at the Department of Medicine, Kungälv Hospital, and a PhD-student in Björn Redfors group at the department of Molecular and Clinical Medicine at the University of Gothenburg. Sandeep was born and raised in Mumbai, India, and received his medical degree in 2007 from the St. Petersburg Medical I.P Pavlov Univeristy, Russia. Sandeep enjoys teaching, cooking and sports. When he is not at work, he spends time with his family and friends.
Rickard Zeijlon MD, PhD
Postdoc
Dr Rickard Zeijlon is a Postdoctoral Research Fellow in Clinical Cardiology at the department of Molecular and Clinical Medicine (Sahlgrenska Academy/University of Gothenburg, Sweden) and a member of Dr Björn Redfors group. He graduated medical school in 2011 (University of Lund, Sweden) and became a licensed physician in 2014 (Sahlgrenska University Hospital, Gothenburg). After residency at the Department of Internal Medicine at Sahlgrenska University Hospital, he became a consultant physician in 2020 and earned his PhD in medical science in 2022 (Sahlgrenska Academy). Rickard is also active in education as the Sahlgrenska University Hospital Head Director of Studies for medical interns. Outside of working hours, Rickard enjoys spending time with family and friends, playing guitar and occasionally soccer.
Sigurdur Thorleifsson, MD
PhD student
Sigurdur James Thorleifsson is a consultant in internal medicine and cardiology at the Department of Cardiology, Sahlgrenska University Hospital, and a PhD-student in Björn Redfors group at the department of Molecular and Clinical Medicine at the University of Gothenburg. Sigurdur was born and raised in Reykjavik, Iceland, and received his medical degree in 2009 from the University of Iceland. In his spare time he enjoys spending time with his family and friends, likes cooking and playing football.
Abhishek Jha
Research assistant
Abhishek Jha is research assistant in Björn Redfors Group.
I recently completed my pharmacy education from Karnataka University in India.
I enjoy work and to learn new tasks in the lab.
Apart from work I like to read and watch movies and series.
Christina Pettersson
Degree in radiography
Christina Pettersson is a certified radiology nurse specialised in magnetic resonance imaging at the department of Radiology, Sahlgrenska University Hospital also, a PhD student and joined the Björn Redfors group in 2022. She graduated as a CRN with an BS degree in 2014. She has previously attended in other research projects, in 2021, she received her MSc degree in radiography. When not at work, she is spending time with family and friends or working out.
Julia Baranowska, MD
PhD-student
Julia Baranowska is a PhD-student in Björn Redfors group at the department of Molecular and Clinical Medicine at the University of Gothenburg.
She received her medical degree from the University of Gothenburg in 2019. During her studies she gained international experience through exchanges to England, Ireland, China and the US. She wrote her master thesis about aortic valve replacement at Weill Cornell Medicine in NYC. In her spare time she enjoys traveling, spending time with family and friends and appreciating various forms of art.
Monica Fagerberg
Research administrator (Forskningsadministratör)
Linnea Molander
Research Student Assistant
Linnea Molander assists with clinical trials, collection of data and analysis. Previously she conducted basic research investigating signaling transduction pathways related to neuroblastoma, using Drosophila melanogaster as a model organism. In her free time she enjoys playing tennis and spending time with her family.
Sabin Salahuddin
PhD-student
Sabin Salahuddin is PhD student in Björn Redfors group at the Department of Molecular and Clinical Medicine at the University of Gothenburg. Sabin completed both her Masters in Dental Surgery (DDS) and obtained her diploma as a medical doctor (MD) from the University of Gothenburg.
Sabins role entails working within the clinical projects in the group with a special interest towards intensive care.
When not working Sabin enjoys time with family and friends, sports and travel.
Zahra Sheybani, MSc
Molecular biologist
Zahra Sheybani is a molecular biologist experienced in molecular medicine and cancer biology working as a research associate in Björn Redfors group at the Department of Molecular and Clinical Medicine at the University of Gothenburg, Sweden. She obtained her master’s degree in 2019 in Iran and moved to Sweden in 2021 to conduct a scholarship-funded research project on redox regulation in CML stem cells, in the department of biomedicine of the university of Gothenburg. She enjoys reading, spending time with friends, and playing badminton in her leisure time.
Tetiana Pylova
Researcher, MD, PhD
Tetiana Pylova is a researcher at the Department of Molecular and Clinical Medicine at the University of Gothenburg. Take part in experimental cardiology research in Björn Redfors group. Obtain medical degree in Kharkiv National Medical University (Ukraine) in 2015. Tetiana has a clinical and research experience in Cardiology and Intervention cardiology. She has PhD degree in Medicine (field of interest- Cardiology). Fond of physical activities, especially volleyball and squash, travelling, spending time with family or friends and baking desserts.
Valentyna Sevastianova
Researcher and specialist
Valentyna Sevastianova is a researcher and specialist in internal medicine, from Ukraine. Her PhD is dedicated to optimization of diagnosis and treatment of cardiac failure in ischemic heart disease with concomitant autoimmune thyroiditis. She has been working in the department of radiation pathology of SO «Grigoriev Institute for Medical Radiology and Oncology of the National Academy of Medical Sciences of Ukraine». Now she is working as a researcher in Björn Redfors group at the department of Molecular and Clinical Medicine at the University of Gothenburg. In her spare time, she enjoys spending time with family and studying Swedish.
Amin Al-Awar
Postdoc
Dr Amin Al-Awar is researcher in Experimental Cardiology in Björn Redfors group, at the Department of Molecular & Clinical Medicine, University of Gothenburg. He holds a master’s degree in Biochemistry, with research focuses on Diabetes. He received his doctoral degree in Biological Sciences in 2018 from Szeged University, Department of Physiology, Anatomy & Neuroscience in Hungary. In his PhD, he studied the effect of anti-diabetic drugs on myocardial infarction. 2019-2020, he did his first postdoctoral studies at Karolinska Institute in the Molecular Cardiology group, Department of Medicine, under the supervision of Dr. Francesco Cosentino. Then he joined as a postdoctoral researcher Dr. Eva Forssell-Aronsson’s group at Gothenburg University, Department of Medical Radiation Sciences & Sahlgrenska Cancer Center, from 2021-2022. His research aims to unmask novel mechanisms underlying vascular and cardiac dysfunction in ischemic heart disease and cardiometabolic disorders, to develop new therapeutic strategies. He taught different courses throughout his academic journey. He enjoys working in multicultural research environments, & he likes teaching & public speaking.
Axel Andersson
PhD
Dr. Axel Andersson is the scientific coordinator of Björn Redfors group at the Department of Molecular and Clinical Medicine at the University of Gothenburg. He attended Umeå University and performed research projects studying molecular aspect of ALS, endocannabinoid pharmacology, 3D pancreas imaging, and glioblastoma metabolomics until 2017 when he obtained his MSc in Biomedicine. Before joining the Redfors group, he received a PhD in Medical Sciences from the Sahlgrenska Academy in early 2022 for researching cerebrovascular aspects in preclinical models of different neonatal brain injuries under Dr. Joakim Ek and Prof. Carina Mallard. When he is not working, he is generally found at a concert, out for a walk, with friends, or in the kitchen.
Vagner Ramon Rodrigues Silva
Researcher
Research opportunities in the Laboratory
Key Publications
-
Zeijlon R, Chamat J, Enabtawi I, Jha S, Mohammed MM, Wågerman J, Le V, Shekka Espinosa A, Nyman E, Omerovic E, Redfors B.
Risk of in-hospital life-threatening ventricular arrhythmia or death after ST-elevation myocardial infarction vs. the Takotsubo syndrome.
ESC Heart Fail. 2021. - Redfors B, Mohebi R, Giustino G, Chen S, Selker HP, Thiele H, Patel MR, Udelson JE, Ohman EM, Eitel I, Granger CB, Maehara A, Ali ZA, Ben-Yehuda O, Stone GW.
Time Delay, Infarct Size and Microvascular Obstruction After Primary PCI for ST-Segment Elevation Myocardial Infarction.
Circ Cardiovasc Interv. 2021. - Redfors B, Furer A, Selker HP, Thiele H, Patel MR, Chen S, Udelson JE, Ohman EM, Eitel I, Granger CB, Maehara A, Kirtane AJ, Généreux P, Jenkins PL, Ben-Yehuda O, Stone GW.
Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI.
J Am Coll Cardiol. 2020;75(15):1743-54. - Jha S, Zeijlon R, Enabtawi I, Espinosa AS, Chamat J, Omerovic E, Redfors B.
Electrocardiographic predictors of adverse in-hospital outcomes in the Takotsubo syndrome.
Int J Cardiol. 2020;299:43-8.
1. Zeijlon R, Chamat J, Enabtawi I, Jha S, Mohammed MM, Wågerman J, Le V, Shekka Espinosa A, Nyman E, Omerovic E, Redfors B. Risk of in-hospital life-threatening ventricular arrhythmia or death after ST-elevation myocardial infarction vs. the Takotsubo syndrome. ESC Heart Fail. 2021.
2. Redfors B, Mohebi R, Giustino G, Chen S, Selker HP, Thiele H, Patel MR, Udelson JE, Ohman EM, Eitel I, Granger CB, Maehara A, Ali ZA, Ben-Yehuda O, Stone GW. Time Delay, Infarct Size and Microvascular Obstruction After Primary PCI for ST-Segment Elevation Myocardial Infarction. Circ Cardiovasc Interv. 2021.
3. Poterucha TJ, Elias P, Jain SS, Sayer G, Redfors B, Burkhoff D, Rosenblum H, DeFilippis EM, Gupta A, Lawlor M, Madhavan MV, Griffin J, Raikhelkar J, Fried J, Clerkin KJ, Kim A, Perotte A, Maurer MS, Saluja D, Dizon J, Ehlert FA, Morrow JP, Yarmohammadi H, Biviano AB, Garan H, Rabbani L, Leon MB, Schwartz A, Uriel N, Wan EY. Admission Cardiac Diagnostic Testing with Electrocardiography and Troponin Measurement Prognosticates Increased 30-Day Mortality in COVID-19. J Am Heart Assoc. 2021;10(1):e018476.
4. Farhan S, Redfors B, Maehara A, McAndrew T, Ben-Yehuda O, De Bruyne B, Mehran R, Vogel B, Giustino G, Serruys PW, Mintz GS, Stone GW. Relationship between insulin resistance, coronary plaque, and clinical outcomes in patients with acute coronary syndromes: an analysis from the PROSPECT study. Cardiovasc Diabetol. 2021;20(1):10.
5. Wolny R, Maehara A, Liu Y, Zhang Z, Mintz GS, Redfors B, Madhavan MV, Smits PC, von Birgelen C, Serruys PW, Mehran R, Leon MB, Stone GW. The obesity paradox revisited: body mass index and -long-term outcomes after PCI from a large pooled patient-level database. EuroIntervention. 2020;15(13):1199-208.
6. Völz S, Petursson P, Odenstedt J, Ioanes D, Haraldsson I, Angerås O, Dworeck C, Hirlekar G, Myredal A, Albertsson P, Råmunddal T, Redfors B, Omerovic E. Ticagrelor is Not Superior to Clopidogrel in Patients With Acute Coronary Syndromes Undergoing PCI: A Report from Swedish Coronary Angiography and Angioplasty Registry. J Am Heart Assoc. 2020;9(14):e015990.
7. Völz S, Petursson P, Angerås O, Odenstedt J, Ioanes D, Haraldsson I, Dworeck C, Hirlekar G, Redfors B, Myredal A, Libungan B, Albertsson P, Råmunddal T, Omerovic E. Prognostic impact of percutaneous coronary intervention in octogenarians with non-ST elevation myocardial infarction: A report from SWEDEHEART. Eur Heart J Acute Cardiovasc Care. 2020;9(5):480-7.
8. Völz S, Dworeck C, Redfors B, Pétursson P, Angerås O, Gan LM, Götberg M, Sarno G, Venetsanos D, Grimfärd P, Hofmann R, Jensen J, Björklund F, Danielewicz M, Linder R, Råmunddal T, Fröbert O, Witt N, James S, Erlinge D, Omerovic E. Survival of Patients With Angina Pectoris Undergoing Percutaneous Coronary Intervention With Intracoronary Pressure Wire Guidance. J Am Coll Cardiol. 2020;75(22):2785-99.
9. Tsikas D, Bollenbach A, Hanff E, Beckmann B, Redfors B. Synthesis of homoagmatine and GC-MS analysis of tissue homoagmatine and agmatine: evidence that homoagmatine but not agmatine is a metabolite of pharmacological L-homoarginine in the anesthetized rat. Amino Acids. 2020;52(2):235-45.
10. Shlofmitz E, Jeremias A, Parviz Y, Karimi Galougahi K, Redfors B, Petrossian G, Edens M, Matsumura M, Maehara A, Mintz GS, Stone GW, Shlofmitz RA, Ali ZA. External elastic lamina vs. luminal diameter measurement for determining stent diameter by optical coherence tomography: an ILUMIEN III substudy. Eur Heart J Cardiovasc Imaging. 2020.
11. Shahim B, Redfors B, Chen S, Thiele H, Eitel I, Gkargkoulas F, Crowley A, Ben-Yehuda O, Maehara A, Stone GW. BMI, Infarct Size, and Clinical Outcomes Following Primary PCI: Patient-Level Analysis From 6 Randomized Trials. JACC Cardiovasc Interv. 2020;13(8):965-72.
12. Shahim B, Redfors B, Chen S, Morice MC, Gersh BJ, Puskas JD, Kandzari DE, Merkely B, Horkay F, Crowley A, Serruys PW, Kappetein AP, Sabik JF, 3rd, Ben-Yehuda O, Stone GW. Outcomes After Left Main Coronary Artery Revascularization by Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting According to Smoking Status. Am J Cardiol. 2020;127:16-24.
13. Rubin GA, Kirtane AJ, Chen S, Redfors B, Weisz G, Baber U, Zhang Y, Stuckey TD, Witzenbichler B, Rinaldi MJ, Neumann FJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Brodie BR, Mazzaferri EL, Jr., Mehran R, Ali ZA, Ben-Yehuda O, Stone GW. Impact of high on-treatment platelet reactivity on outcomes following PCI in patients on hemodialysis: An ADAPT-DES substudy. Catheter Cardiovasc Interv. 2020;96(4):793-801.
14. Redfors B, Sharma SK, Saito S, Kini AS, Lee AC, Moses JW, Ali ZA, Feldman RL, Bhatheja R, Stone GW. Novel Micro Crown Orbital Atherectomy for Severe Lesion Calcification: Coronary Orbital Atherectomy System Study (COAST). Circ Cardiovasc Interv. 2020;13(8):e008993.
15. Redfors B, Lin SH. Mediation analysis - an underused approach to cardiovascular research. Coron Artery Dis. 2020;31(7):620-2.
16. Redfors B, Gregson J, Crowley A, McAndrew T, Ben-Yehuda O, Stone GW, Pocock SJ. The win ratio approach for composite endpoints: practical guidance based on previous experience. Eur Heart J. 2020;41(46):4391-9.
17. Redfors B, Furer A, Selker HP, Thiele H, Patel MR, Chen S, Udelson JE, Ohman EM, Eitel I, Granger CB, Maehara A, Kirtane AJ, Généreux P, Jenkins PL, Ben-Yehuda O, Stone GW. Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI. J Am Coll Cardiol. 2020;75(15):1743-54.
18. Oras J, Doueh R, Norberg E, Redfors B, Omerovic E, Dellgren G. Left ventricular dysfunction in potential heart donors and its influence on recipient outcomes. J Thorac Cardiovasc Surg. 2020;159(4):1333-41.e6.
19. Ong G, Pibarot P, Redfors B, Weissman NJ, Jaber WA, Makkar RR, Lerakis S, Gopal D, Khalique O, Kodali SK, Thourani VH, Anwaruddin S, McAndrew T, Zhang Y, Alu MC, Douglas PS, Hahn RT. Diastolic Function and Clinical Outcomes After Transcatheter Aortic Valve Replacement: PARTNER 2 SAPIEN 3 Registry. J Am Coll Cardiol. 2020;76(25):2940-51.
20. Madhavan MV, Redfors B, Ali ZA, Prasad M, Shahim B, Smits PC, von Birgelen C, Zhang Z, Mehran R, Serruys PW, Maehara A, Leon MB, Kirtane AJ, Stone GW. Long-Term Outcomes After Revascularization for Stable Ischemic Heart Disease: An Individual Patient-Level Pooled Analysis of 19 Randomized Coronary Stent Trials. Circ Cardiovasc Interv. 2020;13(4):e008565.
21. Madhavan MV, Kirtane AJ, Redfors B, Généreux P, Ben-Yehuda O, Palmerini T, Benedetto U, Biondi-Zoccai G, Smits PC, von Birgelen C, Mehran R, McAndrew T, Serruys PW, Leon MB, Pocock SJ, Stone GW. Stent-Related Adverse Events >1 Year After Percutaneous Coronary Intervention. J Am Coll Cardiol. 2020;75(6):590-604.
22. Madhavan MV, Bikdeli B, Redfors B, Biondi-Zoccai G, Varunok NJ, Burton JR, Crowley A, Francese DP, Gupta A, Der Nigoghossian C, Chatterjee S, Palmerini T, Benedetto U, You SC, Ohman M, Kastrati A, Steg PG, Gibson CM, Angiolillo DJ, Krumholz HM, Stone GW. Antiplatelet strategies in acute coronary syndromes: design and methodology of an international collaborative network meta-analysis of randomized controlled trials. Minerva Cardioangiol. 2020.
23. Li X, Redfors B, Sáinz-Jaspeado M, Shi S, Martinsson P, Padhan N, Scharin Täng M, Borén J, Levin M, Claesson-Welsh L. Suppressed Vascular Leakage and Myocardial Edema Improve Outcome From Myocardial Infarction. Front Physiol. 2020;11:763.
24. Kosmidou I, Liu Y, Zhang Z, Redfors B, Kappetein AP, Serruys PW, Gersh BJ, Kandzari DE, Morice MC, Buszman PE, Bochenek A, Schampaert E, Sabik JF, 3rd, Ben-Yehuda O, Stone GW. Incidence and Prognostic Impact of Atrial Fibrillation After Discharge Following Revascularization for Significant Left Main Coronary Artery Narrowing. Am J Cardiol. 2020;125(4):500-6.
25. Kosmidou I, Lindenfeld J, Abraham WT, Kar S, Lim DS, Mishell JM, Whisenant BK, Kipperman RM, Boudoulas KD, Redfors B, Shahim B, Zhang Z, Mack MJ, Stone GW. Transcatheter Mitral Valve Repair in Patients With and Without Cardiac Resynchronization Therapy: The COAPT Trial. Circ Heart Fail. 2020;13(11):e007293.
26. Kosmidou I, Leon MB, Zhang Y, Serruys PW, von Birgelen C, Smits PC, Ben-Yehuda O, Redfors B, Madhavan MV, Maehara A, Mehran R, Stone GW. Long-Term Outcomes in Women and Men Following Percutaneous Coronary Intervention. J Am Coll Cardiol. 2020;75(14):1631-40.
27. Jha S, Zeijlon R, Enabtawi I, Espinosa AS, Chamat J, Omerovic E, Redfors B. Electrocardiographic predictors of adverse in-hospital outcomes in the Takotsubo syndrome. Int J Cardiol. 2020;299:43-8.
28. Jain SS, Liu Q, Raikhelkar J, Fried J, Elias P, Poterucha TJ, DeFilippis EM, Rosenblum H, Wang EY, Redfors B, Clerkin K, Griffin JM, Wan EY, Abdalla M, Bello NA, Hahn RT, Shimbo D, Weiner SD, Kirtane AJ, Kodali SK, Burkhoff D, Rabbani LE, Schwartz A, Leon MB, Homma S, Di Tullio MR, Sayer G, Uriel N, Anstey DE. Indications for and Findings on Transthoracic Echocardiography in COVID-19. J Am Soc Echocardiogr. 2020;33(10):1278-84.
29. Huang X, Chen S, Redfors B, Zhang Y, Souza CF, Mehran R, Bansilal S, Kirtane AJ, Brener SJ, Feite F, Dangas GD, Ben-Yehuda O, Stone GW. Safety and efficacy of bivalirudin monotherapy in patients with non-ST-segment elevation acute coronary syndromes with positive biomarkers undergoing percutaneous coronary intervention: a report from the Acute Catheterization and Urgent Intervention Triage Strategy trial. Coron Artery Dis. 2020;31(1):59-65.
30. Hahn RT, Asch F, Weissman NJ, Grayburn P, Kar S, Lim S, Ben-Yehuda O, Shahim B, Chen S, Liu M, Redfors B, Medvedofsky D, Puri R, Kapadia S, Sannino A, Lindenfeld J, Abraham WT, Mack MJ, Stone GW. Impact of Tricuspid Regurgitation on Clinical Outcomes: The COAPT Trial. J Am Coll Cardiol. 2020;76(11):1305-14.
31. Gupta A, Madhavan MV, Poterucha TJ, DeFilippis EM, Hennessey JA, Redfors B, Eckhardt C, Bikdeli B, Platt J, Nalbandian A, Elias P, Cummings MJ, Nouri SN, Lawlor M, Ranard LS, Li J, Boyle C, Givens R, Brodie D, Krumholz HM, Stone GW, Sethi SS, Burkhoff D, Uriel N, Schwartz A, Leon MB, Kirtane AJ, Wan EY, Parikh SA. Association Between Antecedent Statin Use and Decreased Mortality in Hospitalized Patients with COVID-19. Res Sq. 2020.
32. Guedeney P, Claessen BE, Mehran R, Mintz GS, Liu M, Sorrentino S, Giustino G, Farhan S, Leon MB, Serruys PW, Smits PC, von Birgelen C, Ali ZA, Généreux P, Redfors B, Madhavan MV, Ben-Yehuda O, Stone GW. Coronary Calcification and Long-Term Outcomes According to Drug-Eluting Stent Generation. JACC Cardiovasc Interv. 2020;13(12):1417-28.
33. Gregson J, Stone GW, Ben-Yehuda O, Redfors B, Kandzari DE, Morice MC, Leon MB, Kosmidou I, Lembo NJ, Brown WM, 3rd, Karmpaliotis D, Banning AP, Pomar J, Sabaté M, Simonton CA, Dressler O, Kappetein AP, Sabik JF, 3rd, Serruys PW, Pocock SJ. Implications of Alternative Definitions of Peri-Procedural Myocardial Infarction After Coronary Revascularization. J Am Coll Cardiol. 2020;76(14):1609-21.
34. Golomb M, Redfors B, Crowley A, Smits PC, Serruys PW, von Birgelen C, Madhavan MV, Ben-Yehuda O, Mehran R, Leon MB, Stone GW. Prognostic Impact of Race in Patients Undergoing PCI: Analysis From 10 Randomized Coronary Stent Trials. JACC Cardiovasc Interv. 2020;13(13):1586-95.
35. Faggioni M, Redfors B, Crowley A, Claessen BE, Farhan S, Mastoris I, Witzenbichler B, Maehara A, Weisz G, Généreux P, Ben-Yehuda O, Mehran R, Kirtane AJ, Stone GW. Comparison of Age (<75 Years Vs ≥75 Years) and Platelet Reactivity to the Risk of Thrombotic and Bleeding Events After Successful Percutaneous Coronary Intervention With Drug-Eluting Stents (from the ADAPT-DES Study). Am J Cardiol. 2020;125(5):685-93.
36. Elias P, Poterucha TJ, Jain SS, Sayer G, Raikhelkar J, Fried J, Clerkin K, Griffin J, DeFilippis EM, Gupta A, Lawlor M, Madhavan M, Rosenblum H, Roth ZB, Natarajan K, Hripcsak G, Perotte A, Wan EY, Saluja A, Dizon J, Ehlert F, Morrow JP, Yarmohammadi H, Kumaraiah D, Redfors B, Gavin N, Kirtane A, Rabbani L, Burkhoff D, Moses J, Schwartz A, Leon M, Uriel N. The Prognostic Value of Electrocardiogram at Presentation to Emergency Department in Patients With COVID-19. Mayo Clin Proc. 2020;95(10):2099-109.
37. Dworeck C, Redfors B, Völz S, Haraldsson I, Angerås O, Råmunddal T, Ioanes D, Myredal A, Odenstedt J, Hirlekar G, Koul S, Fröbert O, Linder R, Venetsanos D, Hofmann R, Ulvenstam A, Petursson P, Sarno G, James S, Erlinge D, Omerovic E. Radial artery access is associated with lower mortality in patients undergoing primary PCI: a report from the SWEDEHEART registry. Eur Heart J Acute Cardiovasc Care. 2020;9(4):323-32.
38. Dworeck C, Redfors B, Angerås O, Haraldsson I, Odenstedt J, Ioanes D, Petursson P, Völz S, Persson J, Koul S, Venetsanos D, Ulvenstam A, Hofmann R, Jensen J, Albertsson P, Råmunddal T, Jeppsson A, Erlinge D, Omerovic E. Association of Pretreatment With P2Y12 Receptor Antagonists Preceding Percutaneous Coronary Intervention in Non-ST-Segment Elevation Acute Coronary Syndromes With Outcomes. JAMA Netw Open. 2020;3(10):e2018735.
39. Cheng Y, Ferrone M, Wang Q, Perkins LEL, McGregor J, Redfors B, Zhou Z, Rapoza R, Conditt GB, Finn A, Virmani R, Kaluza GL, Granada JF. Impact of Coronary Atherosclerosis on Bioresorbable Vascular Scaffold Resorption and Vessel Wall Integration. JACC Basic Transl Sci. 2020;5(6):619-29.
40. Chen S, Redfors B, O'Neill BP, Clavel MA, Pibarot P, Elmariah S, Nazif T, Crowley A, Ben-Yehuda O, Finn MT, Alu MC, Vahl TP, Kodali S, Leon MB, Lindman BR. Low and elevated B-type natriuretic peptide levels are associated with increased mortality in patients with preserved ejection fraction undergoing transcatheter aortic valve replacement: an analysis of the PARTNER II trial and registry. Eur Heart J. 2020;41(8):958-69.
41. Chen S, Redfors B, Nazif T, Kirtane A, Crowley A, Ben-Yehuda O, Kapadia S, Finn MT, Goel S, Lindman BR, Alu MC, Chau KH, Thourani VH, Vahl TP, Douglas PS, Kodali SK, Leon MB. Impact of renin-angiotensin system inhibitors on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis of from the PARTNER 2 trial and registries. Eur Heart J. 2020;41(8):943-54.
42. Chen S, Redfors B, Crowley A, Ben-Yehuda O, Summers M, Hahn RT, Jaber WA, Pibarot P, Alu MC, Chau KH, Kapadia S, Nazif T, Vahl TP, Thourani V, Kodali S, Leon M. Impact of recent heart failure hospitalization on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis from the PARTNER 2 trial and registries. Eur J Heart Fail. 2020;22(10):1866-74.
43. Bikdeli B, McAndrew T, Crowley A, Chen S, Mehdipoor G, Redfors B, Liu Y, Zhang Z, Liu M, Zhang Y, Francese DP, Erlinge D, James SK, Han Y, Li Y, Kastrati A, Schüpke S, Stables RH, Shahzad A, Steg PG, Goldstein P, Frigoli E, Mehran R, Valgimigli M, Stone GW. Individual Patient Data Pooled Analysis of Randomized Trials of Bivalirudin versus Heparin in Acute Myocardial Infarction: Rationale and Methodology. Thromb Haemost. 2020;120(2):348-62.
44. Ben-Yehuda O, Shahim B, Chen S, Liu M, Redfors B, Hahn RT, Asch FM, Weissman NJ, Medvedofsky D, Puri R, Kapadia S, Sannino A, Grayburn P, Kar S, Lim S, Lindenfeld J, Abraham WT, Mack MJ, Stone GW. Pulmonary Hypertension in Transcatheter Mitral Valve Repair for Secondary Mitral Regurgitation: The COAPT Trial. J Am Coll Cardiol. 2020;76(22):2595-606.
45. Ali A, Redfors B, Lundgren J, Alkhoury J, Oras J, Gan LM, Omerovic E. The importance of heart rate in isoprenaline-induced takotsubo-like cardiac dysfunction in rats. ESC Heart Fail. 2020;7(5):2690-9.
46. Yadav M, Mintz GS, Généreux P, Liu M, McAndrew T, Redfors B, Madhavan MV, Leon MB, Stone GW. The Smoker's Paradox Revisited: A Patient-Level Pooled Analysis of 18 Randomized Controlled Trials. JACC Cardiovasc Interv. 2019;12(19):1941-50.
47. Shlofmitz E, Généreux P, Chen S, Dressler O, Ben-Yehuda O, Morice MC, Puskas JD, Taggart DP, Kandzari DE, Crowley A, Redfors B, Mehdipoor G, Kappetein AP, Sabik JF, 3rd, Serruys PW, Stone GW. Left Main Coronary Artery Disease Revascularization According to the SYNTAX Score. Circ Cardiovasc Interv. 2019;12(9):e008007.
48. Rinaldi MJ, Gohs FX, Kirtane AJ, Brodie BR, Stuckey TD, Redfors B, McAndrew T, Witzenbichler B, Weisz G, Neumann FJ, Metzger DC, Maehara A, Généreux P, Mehran R, Stone GW. Impact of Point-of-Care Platelet Function Testing Among Patients With and Without Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents (from the ADAPT-DES Study). Am J Cardiol. 2019;123(4):549-57.
49. Redfors B, Stone GW. Myocardial viability and CABG surgery: a Bayesian appraisal of STICH. Nat Rev Cardiol. 2019;16(12):702-3.
50. Redfors B, Dworeck C, Haraldsson I, Angerås O, Odenstedt J, Ioanes D, Petursson P, Völz S, Albertsson P, Råmunddal T, Persson J, Koul S, Erlinge D, Omerovic E. Pretreatment with P2Y12 receptor antagonists in ST-elevation myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry. Eur Heart J. 2019;40(15):1202-10.
51. Redfors B, Chen S, Généreux P, Witzenbichler B, Weisz G, Stuckey TD, Maehara A, McAndrew T, Mehran R, Ben-Yehuda O, Kirtane AJ, Stone GW. Relationship Between Stent Diameter, Platelet Reactivity, and Thrombotic Events After Percutaneous Coronary Artery Revascularization. Am J Cardiol. 2019;124(9):1363-71.
52. Redfors B, Chen S, Ben-Yehuda O, Huang X, Witzenbichler B, Weisz G, Liu Y, Brodie BR, Rinaldi MJ, Neumann FJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Mazzaferri EL, Jr., Mehran R, Stuckey TD, Kirtane AJ, Stone GW. Association Between Hypertension, Platelet Reactivity, and the Risk of Adverse Events After Percutaneous Coronary Intervention (From the ADAPT-DES Study). Am J Cardiol. 2019;124(9):1380-8.
53. Mardani I, Tomas Dalen K, Drevinge C, Miljanovic A, Ståhlman M, Klevstig M, Scharin Täng M, Fogelstrand P, Levin M, Ekstrand M, Nair S, Redfors B, Omerovic E, Andersson L, Kimmel AR, Borén J, Levin MC. Plin2-deficiency reduces lipophagy and results in increased lipid accumulation in the heart. Sci Rep. 2019;9(1):6909.
54. Koyama K, Mintz GS, Redfors B, Serruys PW, De Bruyne B, Erlinge D, Stone GW, Maehara A. Impact of the Extent of Circumferential Plaque on Nonculprit Lesion-Related Events: A PROSPECT Substudy. JACC Cardiovasc Imaging. 2019;12(9):1883-5.
55. Kosmidou I, Redfors B, Chen S, Crowley A, Lembo NJ, Karmpaliotis D, Brown WM, 3rd, Maupas E, Durrleman N, Shah A, Reardon MJ, Dressler O, Ben-Yehuda O, Kappetein AP, Sabik JF, 3rd, Serruys PW, Stone GW. C-reactive protein and prognosis after percutaneous coronary intervention and bypass graft surgery for left main coronary artery disease: Analysis from the EXCEL trial. Am Heart J. 2019;210:49-57.
56. Konigstein M, Madhavan MV, Ben-Yehuda O, Rahim HM, Srdanovic I, Gkargkoulas F, Mehdipoor G, Shlofmitz E, Maehara A, Redfors B, Gore AK, McAndrew T, Stone GW, Ali ZA. Incidence and predictors of target lesion failure in patients undergoing contemporary DES implantation-Individual patient data pooled analysis from 6 randomized controlled trials. Am Heart J. 2019;213:105-11.
57. Jha S, Zeijlon R, Shekka Espinosa A, Alkhoury J, Oras J, Omerovic E, Redfors B. Clinical management in the takotsubo syndrome. Expert Rev Cardiovasc Ther. 2019;17(2):83-93.
58. Jha S, Zeijlon R, Enabtawi I, Espinosa AS, Chamat J, Omerovic E, Redfors B. RE: Do electrocardiogram low amplitude QRS complexes predict adverse in-hospital outcomes in patients with takotsubo syndrome? Int J Cardiol. 2019;297:18.
59. Huang X, Redfors B, Chen S, Liu Y, Ben-Yehuda O, Puskas JD, Kandzari DE, Merkely B, Horkay F, van Boven AJ, Boonstra PW, Sabik JF, Serruys PW, Kappetein AP, Stone GW. Impact of chronic obstructive pulmonary disease on prognosis after percutaneous coronary intervention and bypass surgery for left main coronary artery disease: an analysis from the EXCEL trial. Eur J Cardiothorac Surg. 2019;55(6):1144-51.
60. Huang X, Redfors B, Chen S, Gersh BJ, Mehran R, Zhang Y, McAndrew T, Ben-Yehuda O, Mintz GS, Stone GW. Predictors of mortality in patients with non-anterior ST-segment elevation myocardial infarction: Analysis from the HORIZONS-AMI trial. Catheter Cardiovasc Interv. 2019;94(2):172-80.
61. Haraldsson I, Gan LM, Svedlund S, Torngren K, Westergren HU, Redfors B, Lagerström-Fermér M, Angerås O, Råmunddal T, Petursson P, Odenstedt J, Albertsson P, Erlinge D, Omerovic E. PROspective evaluation of coronary FLOW reserve and molecular biomarkers in patients with established coronary artery disease the PROFLOW-trial: cross-sectional evaluation of coronary flow reserve. Vasc Health Risk Manag. 2019;15:375-84.
62. Furer A, Chen S, Redfors B, Elmariah S, Pibarot P, Herrmann HC, Hahn RT, Kodali S, Thourani VH, Douglas PS, Alu MC, Fearon WF, Passeri J, Malaisrie SC, Crowley A, McAndrew T, Genereux P, Ben-Yehuda O, Leon MB, Burkhoff D. Effect of Baseline Left Ventricular Ejection Fraction on 2-Year Outcomes After Transcatheter Aortic Valve Replacement: Analysis of the PARTNER 2 Trials. Circ Heart Fail. 2019;12(8):e005809.
63. Fujino A, Kadohira T, Redfors B, Maehara A, Serruys PW, Mintz GS, Stone GW, Généreux P. Significant association among residual SYNTAX score, non-culprit major adverse cardiac events, and greyscale and virtual histology intravascular ultrasound findings: a substudy from the PROSPECT study. EuroIntervention. 2019;14(16):1676-84.
64. Finn MT, Redfors B, Karmpaliotis D, Kirtane AJ, Green P, McAndrew T, Liu M, Cloney MB, Witzenbichler B, Weisz G, Stuckey TD, Brodie BR, Rinaldi MJ, Neumann FJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Mazzaferri EL, Jr., Mehran R, Stone GW. Adverse events in patients with high platelet reactivity following successful chronic total occlusion PCI: The Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study. Am Heart J. 2019;211:68-76.
65. Finn MT, Doshi D, Cleman J, Song L, Maehara A, Hatem R, Redfors B, Kalra S, Fried JA, Liao M, Batres C, Moses JW, Parikh MA, Collins MB, Nazif TM, Fall KN, Green P, Kirtane AJ, Ali ZA, Leon MB, Mintz GS, Karmpaliotis D. Intravascular ultrasound analysis of intraplaque versus subintimal tracking in percutaneous intervention for coronary chronic total occlusions: One year outcomes. Catheter Cardiovasc Interv. 2019;93(6):1048-56.
66. Farhan S, Redfors B, Maehara A, McAndrew T, Ben-Yehuda O, De Bruyne B, Mehran R, Giustino G, Kirtane AJ, Serruys PW, Mintz GS, Stone GW. Impact of Pre-Diabetes on Coronary Plaque Composition and Clinical Outcome in Patients With Acute Coronary Syndromes: An Analysis From the PROSPECT Study. JACC Cardiovasc Imaging. 2019;12(4):733-41.
67. Chen S, Redfors B, Liu Y, Vrolix M, Macaya C, Ben-Yehuda O, Kappetein AP, Sabik JF, 3rd, Serruys PW, Stone GW. Outcomes of patients with and without baseline lipid-lowering therapy undergoing revascularization for left main coronary artery disease: analysis from the EXCEL trial. Coron Artery Dis. 2019;30(2):143-9.
68. Chen S, Karmpaliotis D, Redfors B, Shlofmitz E, Ben-Yehuda O, Crowley A, Mehdipoor G, Puskas JD, Kandzari DE, Banning AP, Morice MC, Taggart DP, Sabik JF, 3rd, Serruys PW, Kappetein AP, Stone GW. Does an occluded RCA affect prognosis in patients undergoing PCI or CABG for left main coronary artery disease? Analysis from the EXCEL trial. EuroIntervention. 2019;15(6):e531-e8.
69. Ben-Yehuda O, Chen S, Redfors B, McAndrew T, Crowley A, Kosmidou I, Kandzari DE, Puskas JD, Morice MC, Taggart DP, Leon MB, Lembo NJ, Brown WM, Simonton CA, Dressler O, Kappetein AP, Sabik JF, Serruys PW, Stone GW. Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trial. Eur Heart J. 2019;40(24):1930-41.
70. Ali A, Redfors B, Lundgren J, Alkhoury J, Oras J, Gan LM, Omerovic E. Effects of pretreatment with cardiostimulants and beta-blockers on isoprenaline-induced takotsubo-like cardiac dysfunction in rats. Int J Cardiol. 2019;281:99-104.
71. Völz S, Angerås O, Odenstedt J, Ioanes D, Haraldsson I, Dworeck C, Redfors B, Råmunddal T, Albertsson P, Petursson P, Omerovic E. Sustained risk of stent thrombosis and restenosis in first generation drug-eluting Stents after One Decade of Follow-up: A Report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Catheter Cardiovasc Interv. 2018;92(6):E403-e9.
72. Redfors B, Kosmidou I, Crowley A, Maehara A, Ben-Yehuda O, Arif A, Dizon JM, Mintz GS, Stone GW. Prognostic significance of QRS fragmentation and correlation with infarct size in patients with anterior ST-segment elevation myocardial infarction treated with percutaneous coronary intervention: Insights from the INFUSE-AMI trial. Int J Cardiol. 2018;253:20-4.
73. Redfors B, Généreux P, Witzenbichler B, Maehara A, Weisz G, McAndrew T, Mehran R, Kirtane AJ, Stone GW. Percutaneous coronary intervention of lesions with in-stent restenosis: A report from the ADAPT-DES study. Am Heart J. 2018;197:142-9.
74. Redfors B, Généreux P, Witzenbichler B, Kirtane AJ, McAndrew T, Weisz G, Stuckey TD, Henry TD, Maehara A, Mehran R, Stone GW. Bleeding Severity After Percutaneous Coronary Intervention. Circ Cardiovasc Interv. 2018;11(3):e005542.
75. Redfors B, Généreux P, Witzenbichler B, Kirtane AJ, Maehara A, Weisz G, Madhavan MV, McAndrew T, Mehran R, Stone GW. Percutaneous coronary intervention of bifurcation lesions and platelet reactivity. Int J Cardiol. 2018;250:92-7.
76. Redfors B, Dworeck C, Angerås O, Haraldsson I, Petursson P, Odenstedt J, Ioanes D, Völz S, Hiller M, Fransson P, Stewart J, Fryklund H, Albertsson P, Råmunddal T, Omerovic E. Prognosis is similar for patients who undergo primary PCI during regular-hours and off-hours: A report from SCAAR. Catheter Cardiovasc Interv. 2018;91(7):1240-9.
77. Redfors B, Chen S, Crowley A, Ben-Yehuda O, Gersh BJ, Lembo NJ, Brown WM, 3rd, Banning AP, Taggart DP, Serruys PW, Kappetein AP, Sabik JF, 3rd, Stone GW. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial. Circulation. 2018;138(5):469-78.
78. Redfors B. Admission heart rate in the Takotsubo syndrome - An early marker of the severity of cardiac dysfunction and the risk of in-hospital complications. Int J Cardiol. 2018;273:52-3.
79. Ong G, Redfors B, Crowley A, Abdel-Qadir H, Harrington A, Liu Y, Lafrenière-Roula M, Leong-Poi H, Peterson MD, Connelly KA. Evaluation of left ventricular reverse remodeling in patients with severe aortic regurgitation undergoing aortic valve replacement: Comparison between diameters and volumes. Echocardiography. 2018;35(2):142-7.
80. Koul S, Smith JG, Götberg M, Omerovic E, Alfredsson J, Venetsanos D, Persson J, Jensen J, Lagerqvist B, Redfors B, James S, Erlinge D. No Benefit of Ticagrelor Pretreatment Compared With Treatment During Percutaneous Coronary Intervention in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Circ Cardiovasc Interv. 2018;11(3):e005528.
81. Kosmidou I, Mintz GS, Jatene T, Embacher M, Redfors B, Wong SC, Dressler O, Mehran R, Ben-Yehuda O, Jenkins PL, Stone GW. Impact of bleeding assessment and adjudication methodology on event rates and clinical trial outcomes: insights from the HORIZONS-AMI trial. EuroIntervention. 2018;14(5):e580-e7.
82. Kosmidou I, Chen S, Kappetein AP, Serruys PW, Gersh BJ, Puskas JD, Kandzari DE, Taggart DP, Morice MC, Buszman PE, Bochenek A, Schampaert E, Pagé P, Sabik JF, 3rd, McAndrew T, Redfors B, Ben-Yehuda O, Stone GW. New-Onset Atrial Fibrillation After PCI or CABG for Left Main Disease: The EXCEL Trial. J Am Coll Cardiol. 2018;71(7):739-48.
83. Giustino G, Redfors B, Kirtane AJ, Mehran R, Dangas GD, Witzenbichler B, Neumann FJ, Weisz G, Généreux P, Maehara A, McAndrew T, Farhan S, Rinaldi MJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Mazzaferri EL, Jr., Brodie BR, Stuckey TD, Gurbel P, Ben-Yehuda O, Stone GW. Platelet Reactivity and Risk of Ischemic Stroke After Coronary Drug-Eluting Stent Implantation: From the ADAPT-DES Study. JACC Cardiovasc Interv. 2018;11(13):1277-86.
84. Giustino G, Redfors B, Brener SJ, Kirtane AJ, Généreux P, Maehara A, Dudek D, Neunteufl T, Metzger DC, Crowley A, Mehran R, Gibson CM, Stone GW. Correlates and prognostic impact of new-onset heart failure after ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: insights from the INFUSE-AMI trial. Eur Heart J Acute Cardiovasc Care. 2018;7(4):339-47.
85. Giustino G, Mehran R, Serruys PW, Sabik JF, 3rd, Milojevic M, Simonton CA, Puskas JD, Kandzari DE, Morice MC, Taggart DP, Gershlick AH, Généreux P, Zhang Z, McAndrew T, Redfors B, Ragosta M, 3rd, Kron IL, Dressler O, Leon MB, Pocock SJ, Ben-Yehuda O, Kappetein AP, Stone GW. Left Main Revascularization With PCI or CABG in Patients With Chronic Kidney Disease: EXCEL Trial. J Am Coll Cardiol. 2018;72(7):754-65.
86. Généreux P, Giustino G, Redfors B, Palmerini T, Witzenbichler B, Weisz G, Stuckey TD, Maehara A, Mehran R, Kirtane AJ, Stone GW. Impact of percutaneous coronary intervention extent, complexity and platelet reactivity on outcomes after drug-eluting stent implantation. Int J Cardiol. 2018;268:61-7.
87. Chen S, Redfors B, Liu Y, Ben-Yehuda O, Morice MC, Leon MB, Kandzari DE, Mehran R, Lembo NJ, Banning AP, Merkely B, Kappetein AP, Sabik JF, 3rd, Serruys PW, Stone GW. Radial versus femoral artery access in patients undergoing PCI for left main coronary artery disease: analysis from the EXCEL trial. EuroIntervention. 2018;14(10):1104-11.
88. Chen S, Redfors B, Ben-Yehuda O, Crowley A, Greason KL, Alu MC, Finn MT, Vahl TP, Nazif T, Thourani VH, Suri RM, Svensson L, Webb JG, Kodali SK, Leon MB. Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Prior Cardiac Surgery in the Randomized PARTNER 2A Trial. JACC Cardiovasc Interv. 2018;11(21):2207-16.
89. Angerås O, Haraldsson I, Redfors B, Fröbert O, Petursson P, Albertsson P, Ioanes D, Odenstedt J, Olsson H, Witt N, Rück A, Millgård J, Nilsson J, Persson J, Söderbom M, Wedel H, Erlinge D, James S, Råmunddal T, Omerovic E. Impact of Thrombus Aspiration on Mortality, Stent Thrombosis, and Stroke in Patients With ST-Segment-Elevation Myocardial Infarction: A Report From the Swedish Coronary Angiography and Angioplasty Registry. J Am Heart Assoc. 2018;7(1).
90. Ali ZA, Parviz Y, Brinkman M, Matsumura M, Redfors B, Brogno DA, Corral MD, Fall KN, Mintz GS, Stone GW, Maehara A, Jeremias A, Kirtane AJ. Pressure wire compared to microcatheter sensing for coronary fractional flow reserve: the PERFORM study. EuroIntervention. 2018;14(4):e459-e66.
91. Xu B, Bettinger N, Guan C, Redfors B, Yang Y, Li B, Han Y, Su X, Yuan Z, Généreux P. Impact of completeness of revascularization in complex coronary artery disease as measured with the SYNTAX revascularization index: An SEEDS Substudy. Catheter Cardiovasc Interv. 2017;89(S1):541-8.
92. Saluveer O, Redfors B, Angerås O, Dworeck C, Haraldsson I, Ljungman C, Petursson P, Odenstedt J, Ioanes D, Lundgren P, Völz S, Råmunddal T, Andersson B, Omerovic E, Bergh N. Hypertension is associated with increased mortality in patients with ischaemic heart disease after revascularization with percutaneous coronary intervention - a report from SCAAR. Blood Press. 2017;26(3):166-73.
93. Redfors B, Watson BM, McAndrew T, Palisaitis E, Francese DP, Razavi M, Safirstein J, Mehran R, Kirtane AJ, Généreux P. Mortality, Length of Stay, and Cost Implications of Procedural Bleeding After Percutaneous Interventions Using Large-Bore Catheters. JAMA Cardiol. 2017;2(7):798-802.
94. Redfors B, Pibarot P, Gillam LD, Burkhoff D, Bax JJ, Lindman BR, Bonow RO, O'Gara PT, Leon MB, Généreux P. Stress Testing in Asymptomatic Aortic Stenosis. Circulation. 2017;135(20):1956-76.
95. Redfors B, Palmerini T, Caixeta A, Ayele GM, Francese DP, Mehran R, Brilakis ES, Kirtane AJ, Karmpaliotis D, Stone GW, Généreux P. Impact of Chronic Total Occlusions on Revascularization Scores and Outcome Prediction. J Invasive Cardiol. 2017;29(4):123-31.
96. Redfors B, Maehara A, Witzenbichler B, Weisz G, Stuckey TD, Henry TD, McAndrew T, Mehran R, Kirtane AJ, Stone GW, Généreux P. Outcomes After Successful Percutaneous Coronary Intervention of Calcified Lesions Using Rotational Atherectomy, Cutting-Balloon Angioplasty, or Balloon-Only Angioplasty Before Drug-Eluting Stent Implantation. J Invasive Cardiol. 2017;29(11):378-86.
97. Redfors B, He CH, Palmerini T, Caixeta A, Giustino G, Ayele GM, Kirtane AJ, Mehran R, Stone GW, Généreux P. The SYNTAX Score Does Not Predict Risk of Adverse Events in Patients With Non-ST Elevation Acute Coronary Syndrome Who Undergo Coronary Artery Bypass Graft Surgery. J Invasive Cardiol. 2017;29(2):42-9.
98. Redfors B, Gray WA, Lee RJ, Ellenbogen KA, Bonafede M, Ben-Yehuda O. Patients With Atrial Fibrillation Who Are Not on Anticoagulant Treatment Due to Increased Bleeding Risk Are Common and Have a High Risk of Stroke. JACC Clin Electrophysiol. 2017;3(12):1369-76.
99. Redfors B, Généreux P, Witzenbichler B, McAndrew T, Diamond J, Huang X, Maehara A, Weisz G, Mehran R, Kirtane AJ, Stone GW. Percutaneous Coronary Intervention of Saphenous Vein Graft. Circ Cardiovasc Interv. 2017;10(5).
100. Redfors B, Généreux P. Fetuin-A in aortic stenosis: The pathophysiology crystallizes? Int J Cardiol. 2017;249:434-5.
101. Redfors B, Généreux P. Response by Redfors and Généreux to Letter Regarding Article, "Stress Testing in Asymptomatic Aortic Stenosis". Circulation. 2017;136(19):1868-9.
102. Redfors B, Ben-Yehuda O, Lin SH, Furer A, Kirtane AJ, Witzenbichler B, Weisz G, Stuckey TD, Maehara A, Généreux P, Giustino G, Rinaldi MJ, Neumann FJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Mazzaferri EL, Jr., Ayele GM, Mehran R, Mintz GS, Stone GW. Quantifying Ischemic Risk After Percutaneous Coronary Intervention Attributable to High Platelet Reactivity on Clopidogrel (From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents Study). Am J Cardiol. 2017;120(6):917-23.
103. Kosmidou I, Redfors B, Selker HP, Thiele H, Patel MR, Udelson JE, Magnus Ohman E, Eitel I, Granger CB, Maehara A, Kirtane A, Généreux P, Jenkins PL, Ben-Yehuda O, Mintz GS, Stone GW. Infarct size, left ventricular function, and prognosis in women compared to men after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: results from an individual patient-level pooled analysis of 10 randomized trials. Eur Heart J. 2017;38(21):1656-63.
104. Kosmidou I, Redfors B, McAndrew T, Embacher M, Mehran R, Dizon JM, Ben-Yehuda O, Mintz GS, Stone GW. Worsening atrioventricular conduction after hospital discharge in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: the HORIZONS-AMI trial. Coron Artery Dis. 2017;28(7):550-6.
105. Kosmidou I, Redfors B, Dordi R, Dizon JM, McAndrew T, Mehran R, Ben-Yehuda O, Mintz GS, Stone GW. Incidence, Predictors, and Outcomes of High-Grade Atrioventricular Block in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention (from the HORIZONS-AMI Trial). Am J Cardiol. 2017;119(9):1295-301.
106. Kosmidou I, Redfors B, Crowley A, Gersh B, Chen S, Dizon JM, Embacher M, Mehran R, Ben-Yehuda O, Mintz GS, Stone GW. Prognostic implications of Q waves at presentation in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: An analysis of the HORIZONS-AMI study. Clin Cardiol. 2017;40(11):982-7.
107. Kosmidou I, McAndrew T, Redfors B, Embacher M, Dizon JM, Mehran R, Ben-Yehuda O, Mintz GS, Stone GW. Correlation of Admission Heart Rate With Angiographic and Clinical Outcomes in Patients With Right Coronary Artery ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: HORIZONS-AMI (The Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) Trial. J Am Heart Assoc. 2017;6(7).
108. Günes DN, Kayacelebi AA, Hanff E, Lundgren J, Redfors B, Tsikas D. Metabolism and distribution of pharmacological homoarginine in plasma and main organs of the anesthetized rat. Amino Acids. 2017;49(12):2033-44.
109. Giustino G, Redfors B, Mehran R, Kirtane AJ, Baber U, Généreux P, Witzenbichler B, Neumann FJ, Weisz G, Maehara A, Rinaldi MJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Mazzaferri EL, Jr., Brodie BR, Stuckey TD, Dangas GD, Brener SJ, Ozgu Ozan M, Stone GW. Sex differences in the effect of diabetes mellitus on platelet reactivity and coronary thrombosis: From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study. Int J Cardiol. 2017;246:20-5.
110. Giustino G, Mehran R, Dangas GD, Kirtane AJ, Redfors B, Généreux P, Brener SJ, Prats J, Pocock SJ, Deliargyris EN, Stone GW. Characterization of the Average Daily Ischemic and Bleeding Risk After Primary PCI for STEMI. J Am Coll Cardiol. 2017;70(15):1846-57.
111. Généreux P, Redfors B, Witzenbichler B, Maehara A, Yadav M, Weisz G, Francese DP, Parvataneni R, Brener SJ, Mehran R, Kirtane AJ, Stone GW. Angiographic predictors of 2-year stent thrombosis in patients receiving drug-eluting stents: Insights from the ADAPT-DES study. Catheter Cardiovasc Interv. 2017;89(1):26-35.
112. Généreux P, Redfors B, Witzenbichler B, Arsenault MP, Weisz G, Stuckey TD, Rinaldi MJ, Neumann FJ, Christopher Metzger D, Henry TD, Cox DA, Duffy PL, Mazzaferri EL, Jr., Francese DP, Marquis-Gravel G, Mintz GS, Kirtane AJ, Maehara A, Mehran R, Stone GW. Two-year outcomes after percutaneous coronary intervention of calcified lesions with drug-eluting stents. Int J Cardiol. 2017;231:61-7.
113. Généreux P, Pibarot P, Redfors B, Mack MJ, Makkar RR, Jaber WA, Svensson LG, Kapadia S, Tuzcu EM, Thourani VH, Babaliaros V, Herrmann HC, Szeto WY, Cohen DJ, Lindman BR, McAndrew T, Alu MC, Douglas PS, Hahn RT, Kodali SK, Smith CR, Miller DC, Webb JG, Leon MB. Staging classification of aortic stenosis based on the extent of cardiac damage. Eur Heart J. 2017;38(45):3351-8.
114. Xu B, Redfors B, Yang Y, Qiao S, Wu Y, Chen J, Liu H, Chen J, Xu L, Zhao Y, Guan C, Gao R, Généreux P. Impact of Operator Experience and Volume on Outcomes After Left Main Coronary Artery Percutaneous Coronary Intervention. JACC Cardiovasc Interv. 2016;9(20):2086-93.
115. Redfors B, Kirtane AJ, Pocock SJ, Ayele GM, Deliargyris EN, Mehran R, Stone GW, Généreux P. Bleeding Events Before Coronary Angiography in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome. J Am Coll Cardiol. 2016;68(24):2608-18.
116. Redfors B, Généreux P. Ranolazine following percutaneous coronary intervention: For whom? For what? Expert Rev Cardiovasc Ther. 2016;14(5):541-3.
117. Redfors B, Généreux P. Percutaneous Coronary Intervention for Bifurcation Lesions. Interv Cardiol Clin. 2016;5(2):153-75.
118. Marquis-Gravel G, Redfors B, Leon MB, Généreux P. Medical Treatment of Aortic Stenosis. Circulation. 2016;134(22):1766-84.
119. Giustino G, Mehran R, Bansilal S, Feit F, Lincoff M, Deliargyris EN, Kirtane AJ, Généreux P, Redfors B, Prats J, Bernstein D, Brener SJ, Skerjanec S, Lansky AJ, Francese DP, Dangas GD, Stone GW. Safety and Efficacy of Bivalirudin in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: From the REPLACE-2, ACUITY and HORIZONS-AMI Trials. Am J Cardiol. 2016;118(1):6-16.
120. Giustino G, Chieffo A, Palmerini T, Valgimigli M, Feres F, Abizaid A, Costa RA, Hong MK, Kim BK, Jang Y, Kim HS, Park KW, Gilard M, Morice MC, Sawaya F, Sardella G, Genereux P, Redfors B, Leon MB, Bhatt DL, Stone GW, Colombo A. Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI. J Am Coll Cardiol. 2016;68(17):1851-64.
121. Gennaro G, Brener SJ, Redfors B, Kirtane AJ, Généreux P, Maehara A, Neunteufl T, Metzger DC, Mehran R, Gibson CM, Stone GW. Effect of Smoking on Infarct Size and Major Adverse Cardiac Events in Patients With Large Anterior ST-Elevation Myocardial Infarction (from the INFUSE-AMI Trial). Am J Cardiol. 2016;118(8):1097-104.
122. Généreux P, Stone GW, O'Gara PT, Marquis-Gravel G, Redfors B, Giustino G, Pibarot P, Bax JJ, Bonow RO, Leon MB. Natural History, Diagnostic Approaches, and Therapeutic Strategies for Patients With Asymptomatic Severe Aortic Stenosis. J Am Coll Cardiol. 2016;67(19):2263-88.
123. Généreux P, Kumsars I, Schneider JE, Lesiak M, Redfors B, Cornelis K, Selmon MR, Dens J, Hoye A, Metzger DC, Muyldermans L, Slagboom T, Francese DP, Ayele GM, Laak LL, Bartorelli AL, Cutlip DE, Kaplan AV, Leon MB. Dedicated Bifurcation Stent for the Treatment of Bifurcation Lesions Involving Large Side Branches: Outcomes From the Tryton Confirmatory Study. JACC Cardiovasc Interv. 2016;9(13):1338-46.
124. Généreux P, Bettinger N, Redfors B, Lee AC, Kim CY, Lee MS, Shlofmitz RA, Moses JW, Stone GW, Chambers JW. Two-year outcomes after treatment of severely calcified coronary lesions with the orbital atherectomy system and the impact of stent types: Insight from the ORBIT II trial. Catheter Cardiovasc Interv. 2016;88(3):369-77.
125. Drevinge C, Dalen KT, Mannila MN, Täng MS, Ståhlman M, Klevstig M, Lundqvist A, Mardani I, Haugen F, Fogelstrand P, Adiels M, Asin-Cayuela J, Ekestam C, Gådin JR, Lee YK, Nebb H, Svedlund S, Johansson BR, Hultén LM, Romeo S, Redfors B, Omerovic E, Levin M, Gan LM, Eriksson P, Andersson L, Ehrenborg E, Kimmel AR, Borén J, Levin MC. Perilipin 5 is protective in the ischemic heart. Int J Cardiol. 2016;219:446-54.
126. Ben-Yehuda O, Redfors B. Validation of the Bleeding Academic Research Consortium Bleeding Definition: Towards a Standardized Bleeding Score. J Am Coll Cardiol. 2016;67(18):2145-7.
127. Alkhoury J, Lundgren J, Ali A, Mesinovic D, Redfors B, Omerovic E. Updates on publication trends in Takotsubo syndrome. Int J Cardiol. 2016;221:283-6.
128. Spanos E, Karlsson LO, Redfors B, Shao Y, Omerovic E, Bobrova I, Grip L, Bergh N. Cardioprotection of the enkephalin analog Eribis peptide 94 in a rat model of ischemia and reperfusion is highly dependent on dosing regimen and timing of administration. Eur J Pharmacol. 2015;747:1-6.
129. Singh K, Hibbert B, Bhalla AS, Redfors B. Reply: To PMID 25772741. Am J Cardiol. 2015;115(12):1785-6.
130. Shao Y, Redfors B, Ali A, Bossone E, Lyon A, Omerovic E. McConnell's sign - an insight into the pathogenesis of Takotsubo syndrome? Int J Cardiol. 2015;178:40-3.
131. Shao Y, Redfors B, Ali A, Bossone E, Lyon A, Omerovic E. Takotsubo syndrome and McConnell's phenomenon. Int J Cardiol. 2015;197:349-50.
132. Redfors B, Vedad R, Angerås O, Råmunddal T, Petursson P, Haraldsson I, Ali A, Dworeck C, Odenstedt J, Ioaness D, Libungan B, Shao Y, Albertsson P, Stone GW, Omerovic E. Mortality in takotsubo syndrome is similar to mortality in myocardial infarction - A report from the SWEDEHEART registry. Int J Cardiol. 2015;185:282-9.
133. Redfors B, Shao Y, Ali A, Sun B, Omerovic E. Rat models reveal differences in cardiocirculatory profile between Takotsubo syndrome and acute myocardial infarction. J Cardiovasc Med (Hagerstown). 2015;16(9):632-8.
134. Redfors B, Råmunddal T, Oras J, Karason K, Ricksten SE, Dellgren G, Omerovic E. Successful heart transplantation from a donor with takotsubo syndrome. Int J Cardiol. 2015;195:82-4.
135. Redfors B, Råmunddal T, Angerås O, Dworeck C, Haraldsson I, Ioanes D, Petursson P, Libungan B, Odenstedt J, Stewart J, Robertsson L, Wahlin M, Albertsson P, Herlitz J, Omerovic E. Angiographic findings and survival in patients undergoing coronary angiography due to sudden cardiac arrest in western Sweden. Resuscitation. 2015;90:13-20.
136. Redfors B, Omerovic E. Takotsubo (Stress) Cardiomyopathy. N Engl J Med. 2015;373(27):2688-9.
137. Redfors B, Angerås O, Råmunddal T, Petursson P, Haraldsson I, Dworeck C, Odenstedt J, Ioaness D, Ravn-Fischer A, Wellin P, Sjöland H, Tokgozoglu L, Tygesen H, Frick E, Roupe R, Albertsson P, Omerovic E. Trends in Gender Differences in Cardiac Care and Outcome After Acute Myocardial Infarction in Western Sweden: A Report From the Swedish Web System for Enhancement of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART). J Am Heart Assoc. 2015;4(7).
138. Redfors B, Angerås O, Petursson P, Råmunddal T, Omerovic E. The ATLANTIC trial does not support the safety of prehospital ticagrelor treatment for patients with ST-elevation myocardial infarction. Int J Cardiol. 2015;190:157-8.
139. Redfors B, Ali A, Shao Y, Omerovic E. Re: On the quest of unravelling the pathophysiology of takotsubo syndrome. Int J Cardiol. 2015;184:265-6.
140. Hjalmarsson C, Oras J, Redfors B. A case of intracerebral hemorrhage and apical ballooning: An important differential diagnosis in ST-segment elevation. Int J Cardiol. 2015;186:90-2.
141. Gizurarson S, Ståhlman M, Jeppsson A, Shao Y, Redfors B, Bergfeldt L, Borén J, Omerovic E. Atrial fibrillation in patients admitted to coronary care units in western Sweden - focus on obesity and lipotoxicity. J Electrocardiol. 2015;48(5):853-60.
142. Citro R, Lyon AR, Meimoun P, Omerovic E, Redfors B, Buck T, Lerakis S, Parodi G, Silverio A, Eitel I, Schneider B, Prasad A, Bossone E. Standard and advanced echocardiography in takotsubo (stress) cardiomyopathy: clinical and prognostic implications. J Am Soc Echocardiogr. 2015;28(1):57-74.
143. Bergström G, Redfors B, Angerås O, Dworeck C, Shao Y, Haraldsson I, Petursson P, Milicic D, Wedel H, Albertsson P, Råmunddal T, Rosengren A, Omerovic E. Low socioeconomic status of a patient's residential area is associated with worse prognosis after acute myocardial infarction in Sweden. Int J Cardiol. 2015;182:141-7.
144. Bandaru S, Grönros J, Redfors B, Çil Ç, Pazooki D, Salimi R, Larsson E, Zhou AX, Ömerovic E, Akyürek LM. Deficiency of filamin A in endothelial cells impairs left ventricular remodelling after myocardial infarction. Cardiovasc Res. 2015;105(2):151-9.
145. Andersson L, Scharin Täng M, Lundqvist A, Lindbom M, Mardani I, Fogelstrand P, Shahrouki P, Redfors B, Omerovic E, Levin M, Borén J, Levin MC. Rip2 modifies VEGF-induced signalling and vascular permeability in myocardial ischaemia. Cardiovasc Res. 2015;107(4):478-86.
146. Ali A, Redfors B, Omerovic E. How baroreceptor dysfunction could predispose to the takotsubo syndrome. Int J Cardiol. 2015;182:105-6.
147. Shao Y, Redfors B, Benoist D, Gizurarson S, Omerovic E. Lipid metabolites and their differential pro-arrhythmic profiles: of importance in the development of a new anti-arrhythmic pharmacology. Mol Cell Biochem. 2014;393(1-2):191-7.
148. Redfors B, Shao Y, Wikström J, Lyon AR, Oldfors A, Gan LM, Omerovic E. Contrast echocardiography reveals apparently normal coronary perfusion in a rat model of stress-induced (Takotsubo) cardiomyopathy. Eur Heart J Cardiovasc Imaging. 2014;15(2):152-7.
149. Redfors B, Shao Y, Omerovic E. Influence of anesthetic agent, depth of anesthesia and body temperature on cardiovascular functional parameters in the rat. Lab Anim. 2014;48(1):6-14.
150. Redfors B, Shao Y, Omerovic E. Is stress-induced cardiomyopathy (takotsubo) the cause of elevated cardiac troponins in a subset of septic patients? Intensive Care Med. 2014;40(5):757-8.
151. Redfors B, Shao Y, Omerovic E. International comparisons of acute myocardial infarction. Lancet. 2014;384(9940):304-5.
152. Redfors B, Shao Y, Omerovic E. ["Primum nil nocere" first choice in Takotsubo cardiomyopathy. Mechanical support as a bridge to recovery should be tested in severe cases]. Lakartidningen. 2014;111(34-35):1366-9.
153. Redfors B, Shao Y, Oldfors A, Omerovic E. Normal apical myocardial perfusion in the rat model with Takotsubo syndrome: is subsequent microvascular dysfunction and hypoperfusion an epiphenomenon? Reply. Eur Heart J Cardiovasc Imaging. 2014;15(1):110-1.
154. Redfors B, Shao Y, Lyon AR, Omerovic E. Diagnostic criteria for takotsubo syndrome: a call for consensus. Int J Cardiol. 2014;176(1):274-6.
155. Redfors B, Shao Y, Ali A, Omerovic E. Are ischemic stunning, conditioning, and "takotsubo" different sides to the same coin? Int J Cardiol. 2014;172(2):490-1.
156. Redfors B, Shao Y, Ali A, Omerovic E. Current hypotheses regarding the pathophysiology behind the takotsubo syndrome. Int J Cardiol. 2014;177(3):771-9.
157. Redfors B, Råmunddal T, Shao Y, Omerovic E. Takotsubo triggered by acute myocardial infarction: a common but overlooked syndrome? J Geriatr Cardiol. 2014;11(2):171-3.
158. Redfors B, Oras J, Shao Y, Seemann-Lodding H, Ricksten SE, Omerovic E. Cardioprotective effects of isoflurane in a rat model of stress-induced cardiomyopathy (takotsubo). Int J Cardiol. 2014;176(3):815-21.
159. Redfors B, Oras J, Shao Y, Seemann-Lodding H, Ricksten SE, Omerovic E. Response to "Cardioprotective effect of isoflurane anesthesia from takotsubo syndrome and its implications". Int J Cardiol. 2014;177(3):1080.
160. Redfors B, Ali A, Shao Y, Lundgren J, Gan LM, Omerovic E. Different catecholamines induce different patterns of takotsubo-like cardiac dysfunction in an apparently afterload dependent manner. Int J Cardiol. 2014;174(2):330-6.
161. Shao Y, Redfors B, Tang MS, Assarsson U, Omerovic E. Novel simple approach for detection of regional perturbations of cardiac function in mouse models of cardiovascular disease. Echocardiography. 2013;30(7):843-9.
162. Shao Y, Redfors B, Ståhlman M, Täng MS, Miljanovic A, Möllmann H, Troidl C, Szardien S, Hamm C, Nef H, Borén J, Omerovic E. A mouse model reveals an important role for catecholamine-induced lipotoxicity in the pathogenesis of stress-induced cardiomyopathy. Eur J Heart Fail. 2013;15(1):9-22.
163. Shao Y, Redfors B, Scharin Täng M, Möllmann H, Troidl C, Szardien S, Hamm C, Nef H, Borén J, Omerovic E. Novel rat model reveals important roles of β-adrenoreceptors in stress-induced cardiomyopathy. Int J Cardiol. 2013;168(3):1943-50.
164. Shao Y, Redfors B, Omerovic E. Modified technique for coronary artery ligation in mice. J Vis Exp. 2013(73).
165. Shao Y, Redfors B, Mattson-Hultén L, Scharing Täng M, Daryoni E, Said M, Omerovic E. Adenosine prevents isoprenaline-induced cardiac contractile and electrophysiological dysfunction. Eur J Pharmacol. 2013;718(1-3):475-83.
166. Redfors B, Shao Y, Omerovic E. Stress-induced cardiomyopathy (Takotsubo)--broken heart and mind? Vasc Health Risk Manag. 2013;9:149-54.
167. Redfors B, Shao Y, Omerovic E. Stress-induced cardiomyopathy in the critically ill - why inotropes fail to improve outcome. Int J Cardiol. 2013;168(4):4489-90.
168. Redfors B, Shao Y, Ali A, Omerovic E. Are the different patterns of stress-induced (Takotsubo) cardiomyopathy explained by regional mechanical overload and demand: supply mismatch in selected ventricular regions? Med Hypotheses. 2013;81(5):954-60.
169. Täng MS, Redfors B, Shao Y, Omerovic E. Velocity vector imaging fails to quantify regional myocardial dysfunction in a mouse model of isoprenaline-induced cardiotoxicity. Echocardiography. 2012;29(7):818-26.
170. Shao Y, Redfors B, Lyon AR, Rosengren A, Swedberg K, Omerovic E. Trends in publications on stress-induced cardiomyopathy. Int J Cardiol. 2012;157(3):435-6.
171. Schultz T, Shao Y, Redfors B, Sverrisdóttir YB, Råmunddal T, Albertsson P, Matejka G, Omerovic E. Stress-induced cardiomyopathy in Sweden: evidence for different ethnic predisposition and altered cardio-circulatory status. Cardiology. 2012;122(3):180-6.
172. Redfors B, Shao Y, Råmunddal T, Lindbom M, Täng MS, Stillemark-Billton P, Boren J, Omerovic E. Effects of doxorubicin on myocardial expression of apolipoprotein-B. Scand Cardiovasc J. 2012;46(2):93-8.
173. Redfors B, Shao Y, Omerovic E. Myocardial infarct size and area at risk assessment in mice. Exp Clin Cardiol. 2012;17(4):268-72.
174. Redfors B, Shao Y, Omerovic E. Stress-induced cardiomyopathy in a patient with chronic spinal cord transection at the level of C5: endocrinologically mediated catecholamine toxicity. Int J Cardiol. 2012;159(3):e61-2.
175. Redfors B, Shao Y, Omerovic E. Fatal stress-induced cardiomyopathy in a young patient treated with adrenomimetics. Clin Res Cardiol. 2012;101(11):939-40.
176. Nallapalli RK, Ibrahim MX, Zhou AX, Bandaru S, Sunkara SN, Redfors B, Pazooki D, Zhang Y, Borén J, Cao Y, Bergo MO, Akyürek LM. Targeting filamin A reduces K-RAS-induced lung adenocarcinomas and endothelial response to tumor growth in mice. Mol Cancer. 2012;11:50.
